Journal of the American Academy of Child and Adolescent Psychiatry

Attention-Deficit/Hyperactivity Disorder Subtypes Defined by Cognition Have a Distinct Neural and Clinical Profile and Differ in Response to Atomoxetine: JAACAP May 2026

American Academy of Child and Adolescent Psychiatry

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 22:17

May 2026: Contributing Editor Deepika Shaligram interviews John E. Leikauf on a study that identified new attention-deficit/hyperactivity disorder (ADHD) subtypes using computerized attention-based tasks and compared these new subtypes’ responses to 2 ADHD medications: methylphenidate (stimulant) and atomoxetine (nonstimulant).